We believe that our results are largely valid and conclusions may be justified regarding the associations of S100A12 and RAGE components with amputation- and PAD-free survival, even if adjusted HR fall outside the commonly (miss)used significance limits (i.e. P < 0.05) [55–57]. This evidence concerns the gene AGER and peripheral arterial disease.